{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-067589","form_type":"8-K","ticker":"PTGX","cik":"0001377121","company_name":"Protagonist Therapeutics, Inc","filed_at":"2022-06-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.413894+00:00","generated_at":"2026-06-25T05:04:13.748615+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Protagonist Therapeutics stockholder meeting approves director elections, say-on-pay, and auditor ratification","bullets":["Harold Selick and Bryan Giraudo elected Class III directors with 27.9M and 28.1M votes for, respectively.","Advisory say-on-pay approved: 35.8M for, 0.4M against; 2.4M broker non-votes.","Non-binding vote favored annual say-on-pay frequency (35.6M for 1 year); company intends annual votes.","Ernst & Young ratified as auditor for FY2022: 38.7M for, 5.6K against, 1.5K abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-067589","json":"https://secwatch.observer/filing/0001104659-22-067589.json","markdown":"https://secwatch.observer/filing/0001104659-22-067589.md","text":"https://secwatch.observer/filing/0001104659-22-067589.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1377121/000110465922067589/0001104659-22-067589-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1377121/000110465922067589/tm2217556d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T05:04:13.748615+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}